Elsevier

Thrombosis Research

Volume 199, March 2021, Pages 19-20
Thrombosis Research

Letter to the Editors-in-Chief
Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?

https://doi.org/10.1016/j.thromres.2020.12.013Get rights and content

Keywords

COVID-19
Anticoagulation
Thromboprophylaxis
Dose
Survival

Cited by (0)

View Abstract